Merz Pharmaceuticals, LLC's Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA  
9/11/2009 10:59:03 AM

GREENSBORO, N.C., Sept. 11 /PRNewswire/ -- Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz's premarket approval (PMA) application for Belotero(R) Balance.